HSBC Holdings’s GeneDx Holdings WGS Stock Holding History

HSBC Holdings’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-938	Closed	-$40K	–	3303
2022 Q2	$40K	Sell	938 -137	-13%	-$9.29K	﹤0.01%	3159
2022 Q1	$111K	Buy	1,075 +668	+164%	+$74.3K	﹤0.01%	3106
2021 Q4	$60K	Buy	+407	New	+$90.9K	﹤0.01%	3192

Other funds holding WGS

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

HSBC Holdings's WGS Position: Q3 2022 in Review

HSBC Holdings sold out of GeneDx Holdings (WGS) in Q3 2022, closing a stake of 938 shares — an estimated $40K sold.

HSBC Holdings first reported a position in WGS in Q4 2021 and held it in 3 quarters. The position peaked at $111K in Q1 2022. 98 funds tracked by Wall St. Rank hold WGS as of Q3 2022.

HSBC Holdings reported no remaining GeneDx Holdings position as of Q3 2022 after selling out during the quarter.
HSBC Holdings sold 938 GeneDx Holdings shares in Q3 2022, an estimated $40K.
HSBC Holdings first reported a position in GeneDx Holdings in Q4 2021 and held it in 3 quarters.
HSBC Holdings's GeneDx Holdings position peaked at $111K in Q1 2022.
98 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2022.

Based on HSBC Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.